BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9188832)

  • 21. Elevated environmental temperatures can induce hyperthermia during d-fenfluramine exposure and enhance 5-hydroxytryptamine (5-HT) depletion in the brain.
    Stewart CW; Bowyer JF; Slikker W
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1144-50. PubMed ID: 9399987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The measurement of d-fenfluramine and its metabolite, d-norfenfluramine in plasma and urine with an application of the method to pharmacokinetic studies.
    Richards RP; Gordon BH; Ings RM; Campbell DB; King LJ
    Xenobiotica; 1989 May; 19(5):547-53. PubMed ID: 2750211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic properties of N-nitrosofenfluramine after its administration to rats.
    Kaddoumi A; Wada M; Nakashima K
    Biomed Chromatogr; 2011 May; 25(5):579-87. PubMed ID: 20857399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of fenfluramine to norfenfluramine in guinea-pigs.
    Fuller RW; Snoddy HD; Perry KW
    J Pharm Pharmacol; 1988 Jun; 40(6):439-41. PubMed ID: 2458444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs.
    Mennini T; Bizzi A; Caccia S; Codegoni A; Fracasso C; Frittoli E; Guiso G; Padura IM; Taddei C; Uslenghi A
    Naunyn Schmiedebergs Arch Pharmacol; 1991 May; 343(5):483-90. PubMed ID: 1881458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative activity of the enantiomers of fenfluramine and norfenfluramine in rodent seizure models, and relationship with their concentrations in plasma and brain.
    Erenburg N; Hamed R; Shaul C; Perucca E; Bialer M
    Epilepsia; 2023 Jun; 64(6):1673-1683. PubMed ID: 36995363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma levels of parent compound and metabolites after doses of either d-fenfluramine or d-3,4-methylenedioxymethamphetamine (MDMA) that produce long-term serotonergic alterations.
    Bowyer JF; Young JF; Slikker W; Itzak Y; Mayorga AJ; Newport GD; Ali SF; Frederick DL; Paule MG
    Neurotoxicology; 2003 Jun; 24(3):379-90. PubMed ID: 12782103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of dansyl derivatization and chromatographic conditions in the determination of neuroactive amino acids of biological samples.
    Kang X; Xiao J; Huang X; Gu Z
    Clin Chim Acta; 2006 Apr; 366(1-2):352-6. PubMed ID: 16406032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly sensitive HPLC method for the determination of galantamine in human plasma and urine through derivatization with dansyl chloride using fluorescence detector.
    Ă–zdemir E; Tatar Ulu S
    Luminescence; 2017 Nov; 32(7):1145-1149. PubMed ID: 28430400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gas-liquid chromatographic determination of the optical isomers of fenfluramine and norfenfluramine in biological samples.
    Caccia S; Jori A
    J Chromatogr; 1977 Nov; 144(1):127-31. PubMed ID: 914957
    [No Abstract]   [Full Text] [Related]  

  • 31. The synthesis and biological activity of pentafluorosulfanyl analogs of fluoxetine, fenfluramine, and norfenfluramine.
    Welch JT; Lim DS
    Bioorg Med Chem; 2007 Nov; 15(21):6659-66. PubMed ID: 17765553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropharmacological effects of low and high doses of repeated oral dexfenfluramine in rats: a comparison with fluoxetine.
    Caccia S; Confalonieri S; Bergami A; Fracasso C; Anelli M; Garattini S
    Pharmacol Biochem Behav; 1997 Aug; 57(4):851-6. PubMed ID: 9259015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of d- and l-norfenfluramine following their administration as individual enantiomers in rats.
    Erenburg N; Hamed R; Shaul C; Barasch D; Perucca E; Bialer M
    Epilepsia; 2024 Feb; 65(2):e14-e19. PubMed ID: 38041575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin (5-HT) transporter ligands affect plasma 5-HT in rats.
    Rothman RB; Zolkowska D; Baumann MH
    Ann N Y Acad Sci; 2008 Oct; 1139():268-84. PubMed ID: 18991872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of intracerebroventricular administration of d-fenfluramine and d-norfenfluramine, as a single injection or 2-hr infusion, on serotonin in brain: relationship to concentrations of drugs in brain.
    Invernizzi R; Fracasso C; Caccia S; Garattini S; Samanin R
    Neuropharmacology; 1991 Feb; 30(2):119-23. PubMed ID: 2030819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereoselective Analysis of the Antiseizure Activity of Fenfluramine and Norfenfluramine in Mice: Is
    Erenburg N; Perucca E; Bechard J; Dube C; Weishaupt N; Sherrington R; Bialer M
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous determination of the binding of amantadine and its analogues to synthetic melanin by liquid chromatography after precolumn derivatization with dansyl chloride.
    Higashi Y; Fujii Y
    J Chromatogr Sci; 2005 Apr; 43(4):213-7. PubMed ID: 15975238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solid-phase extraction and analysis of paroxetine in human plasma by ultra performance liquid chromatography-electrospray ionization mass spectrometry.
    Bhatt M; Shah S;
    Biomed Chromatogr; 2010 Feb; 24(2):209-15. PubMed ID: 19591242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of the antidepressant fluoxetine in human plasma by LC with UV detection.
    Maya MT; Domingos CR; Guerreiro MT; Morais JA
    J Pharm Biomed Anal; 2000 Nov; 23(6):989-96. PubMed ID: 11095300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors.
    Vickers SP; Dourish CT; Kennett GA
    Neuropharmacology; 2001 Aug; 41(2):200-9. PubMed ID: 11489456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.